Search

Your search keyword '"Marcoccia, Antonella"' showing total 43 results

Search Constraints

Start Over You searched for: Author "Marcoccia, Antonella" Remove constraint Author: "Marcoccia, Antonella"
43 results on '"Marcoccia, Antonella"'

Search Results

1. Diffusing Capacity of the Lungs for Carbon Monoxide and Echocardiographic Parameters in Identifying Mild Pulmonary Hypertension in the EUSTAR Cohort of Patients With Systemic Sclerosis

2. Cohort Enrichment Strategies for Progressive Interstitial Lung Disease in Systemic Sclerosis From European Scleroderma Trials and Research

3. DLco and echocardiographic parameters in identifying mild pulmonary hypertension in the EUSTAR cohort of systemic sclerosis patients

4. Stratification in systemic sclerosis according to autoantibody status versus skin involvement: a study of the prospective EUSTAR cohort

5. An International Delphi Consensus on Diagnostic Criteria for Buerger's Disease

6. Diffusing Capacity of the Lungs for Carbon Monoxide and Echocardiographic Parameters in Identifying Mild Pulmonary Hypertension in the EUSTAR Cohort of Patients With Systemic Sclerosis.

7. A RAND/UCLA-Modified VAS Study on Telemedicine, Telehealth, and Virtual Care in Daily Clinical Practice of Vascular Medicine

8. A RAND/UCLA-Modified VAS Study on Telemedicine, Telehealth, and Virtual Care in Daily Clinical Practice of Vascular Medicine

9. Vascular Diseases in Women:Do Women Suffer from Them Differently?

10. Vascular Diseases in Women: Do Women Suffer from Them Differently?

11. Diagnostic criteria for Buerger's disease: International Consensus of VAS - European Independent Foundation in Angiology/Vascular Medicine

14. Stratification in systemic sclerosis according to autoantibody status versus skin involvement: a study of the prospective EUSTAR cohort

15. Microcirculatory assessment of vascular diseases

17. Rituximab treatment in a case of antisynthetase syndrome with severe interstitial lung disease and acute respiratory failure

18. Cohort Enrichment Strategies for Progressive Interstitial Lung Disease in Systemic Sclerosis From European Scleroderma Trials and Research

25. COVID-19 Sepsis and Microcirculation Dysfunction

26. Microcirculatory assessment of vascular diseases

28. Undifferentiated connective tissue disease at risk of systemic sclerosis: A weighted score to identify patients who will evolve

30. Guidance for the Management of Patients with Vascular Disease or Cardiovascular Risk Factors and COVID-19: Position Paper from VAS-European Independent Foundation in Angiology/Vascular Medicine

32. Early Systemic Sclerosis: Marker Autoantibody Positive Patients Have A Faster Pace Of The Disease

33. Cardiac involvement in undifferentiated connective tissue disease at risk for systemic sclerosis. A tissue doppler imaging study

34. Early Systemic Sclerosis: Analysis of the Disease Course in Patients With Marker Autoantibody and/or Capillaroscopic Positivity

35. Early systemic sclerosis: marker autoantibodies and videocapillaroscopy patterns are each associated with distinct clinical, functional and cellular activation markers

39. 99mTc-interleukin-2 scintigraphy for the in vivo imaging of vulnerable atherosclerotic plaques.

40. Use of platelet inhibitors for digital ulcers related to systemic sclerosis: EUSTAR study on derivation and validation of the DU-VASC model

41. Racial differences in systemic sclerosis disease presentation: A European Scleroderma Trials and Research group study

42. Significant weight loss in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database

43. Prevalence of autoantibody patterns in a group of patients with early scleroderma

Catalog

Books, media, physical & digital resources